58.06
前日終値:
$55.47
開ける:
$55.77
24時間の取引高:
2.10M
Relative Volume:
0.90
時価総額:
$8.89B
収益:
$700.35M
当期純損益:
$461.90M
株価収益率:
20.23
EPS:
2.8696
ネットキャッシュフロー:
$-14.19M
1週間 パフォーマンス:
+5.68%
1か月 パフォーマンス:
+44.57%
6か月 パフォーマンス:
+91.36%
1年 パフォーマンス:
+61.37%
Tg Therapeutics Inc Stock (TGTX) Company Profile
名前
Tg Therapeutics Inc
セクター
電話
(212) 554-4484
住所
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY
Compare TGTX vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
TGTX
Tg Therapeutics Inc
|
58.06 | 8.49B | 700.35M | 461.90M | -14.19M | 2.8696 |
|
VRTX
Vertex Pharmaceuticals Inc
|
522.25 | 134.41B | 12.34B | 4.34B | 3.71B | 16.87 |
|
REGN
Regeneron Pharmaceuticals Inc
|
676.23 | 68.13B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
919.93 | 57.01B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
321.50 | 41.79B | 4.29B | 577.22M | 641.34M | 4.2086 |
|
RVMD
Revolution Medicines Inc
|
190.46 | 40.39B | 742.00K | -1.37B | -1.07B | -7.0731 |
Tg Therapeutics Inc Stock (TGTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-06 | 再開されました | H.C. Wainwright | Buy |
| 2025-07-10 | 再開されました | Goldman | Neutral |
| 2024-10-29 | 開始されました | TD Cowen | Buy |
| 2023-08-02 | アップグレード | Goldman | Sell → Neutral |
| 2023-06-26 | 再開されました | Jefferies | Buy |
| 2022-05-20 | 開始されました | BofA Securities | Underperform |
| 2022-02-23 | 繰り返されました | B. Riley Securities | Buy |
| 2021-11-15 | ダウングレード | Goldman | Neutral → Sell |
| 2021-04-20 | 開始されました | Goldman | Neutral |
| 2021-04-19 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-09-01 | 開始されました | JP Morgan | Overweight |
| 2020-08-11 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-06-05 | 開始されました | Evercore ISI | Outperform |
| 2020-01-17 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-11-27 | 再開されました | B. Riley FBR | Buy |
| 2019-02-06 | 再開されました | Jefferies | Buy |
| 2018-09-25 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2018-03-09 | 繰り返されました | B. Riley FBR, Inc. | Buy |
| 2017-12-01 | 再開されました | B. Riley FBR, Inc. | Buy |
| 2017-11-14 | 再開されました | H.C. Wainwright | Buy |
| 2017-04-25 | 開始されました | Jefferies | Buy |
| 2017-03-06 | 繰り返されました | FBR & Co. | Outperform |
| 2016-10-06 | 再開されました | Brean Capital | Buy |
| 2016-05-27 | 開始されました | SunTrust | Buy |
| 2015-12-01 | 開始されました | FBR Capital | Outperform |
| 2015-09-09 | 開始されました | Raymond James | Strong Buy |
| 2015-08-12 | 再開されました | H.C. Wainwright | Buy |
| 2015-06-19 | 繰り返されました | Brean Capital | Buy |
| 2014-12-11 | 繰り返されました | ROTH Capital | Buy |
| 2014-12-10 | 繰り返されました | ROTH Capital | Buy |
すべてを表示
Tg Therapeutics Inc (TGTX) 最新ニュース
TGTX Maintained by B of A Securities -- Price Target Raised to $20 - GuruFocus
TG Therapeutics stock hits 52-week high at 57.4 USD - Investing.com
TG Therapeutics, Inc. Stock 12‑Month Price Target Raised to $52.14, Implies 6% Downside - TradingView
TG Therapeutics Begins Phase II Study With Briumvi in Schizophrenia - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
TGTX Reiterated by HC Wainwright & Co. -- Price Target Maintained at $70 - GuruFocus
TG Therapeutics begins schizophrenia Phase 2 trial - grafa.com
TG Therapeutics begins trial of Briumvi for schizophrenia - Investing.com
TG Therapeutics tests BRIUMVI in 60 schizophrenia patients - Stock Titan
TG Therapeutics Reports First Quarter 2026 Financial Results and Raises BRIUMVI Revenue Guidance - marketscreener.com
Will Briumvi's Strength Continue to Aid TGTX's Top Line in Q2? - Yahoo Finance
TGTXTG Therapeutics Inc Dividends - Finviz
TG THERAPEUTICS INC (NASDAQ:TGTX): High-Growth Momentum Meets Minervini Trend Template Technical Strength - ChartMill
TG THERAPEUTICS INC (TGTX) Stock Chart - ChartMill
Price to sales forward of TG Therapeutics, Inc. – NASDAQ:TGTX - TradingView
Price to earnings forward of TG Therapeutics, Inc. – MIL:1TGTX - TradingView
Does TG Therapeutics (NASDAQ:TGTX) Deserve A Spot On Your Watchlist? - Moomoo
TG Therapeutics Surged 88%: Time To Be More Careful (Rating Downgrade) (NASDAQ:TGTX) - Seeking Alpha
Responsive Playbooks and the TGTX Inflection - Stock Traders Daily
TGTX stock continues rally for 8 straight sessions on new BRIUMVI clinical data - MSN
NKB2 Forecast — Price Target — Prediction for 2027 - TradingView
TG Therapeutics (TGTX) soars 7.5%: Is further upside left in the stock? - MSN
TG Therapeutics Board Authorizes New $100M Share Repurchase Program - MSN
Price to earnings forward of TG Therapeutics, Inc. – NASDAQ:TGTX - TradingView
Enterprise value to EBITDA forward of TG Therapeutics, Inc. – FWB:NKB2 - TradingView
Price to book forward of TG Therapeutics, Inc. – FWB:NKB2 - TradingView
Enterprise value to EBIT forward of TG Therapeutics, Inc. – NASDAQ:TGTX - TradingView
Enterprise value to EBIT forward of TG Therapeutics, Inc. – LSX:A1JXW7 - TradingView
Price to sales forward of TG Therapeutics, Inc. – FWB:NKB2 - TradingView
Enterprise value to revenue forward of TG Therapeutics, Inc. – NASDAQ:TGTX - TradingView
TG Therapeutics, Inc. Actuals & Estimates (NASDAQ:TGTX) - TradingView
TG Therapeutics, Inc. Actuals & Estimates (MIL:1TGTX) - TradingView
Price to earnings forward of TG Therapeutics, Inc. – LSX:A1JXW7 - TradingView
Price to sales forward of TG Therapeutics, Inc. – LSX:A1JXW7 - TradingView
TGTX Forecast — Price Target — Prediction for 2027 - TradingView
TGTX Stock Continues Rally For 8 Straight Sessions On New BRIUMVI Clinical Data - Stocktwits
TG Therapeutics Inc (TGTX) Institutional Confidence - TradingKey
TG Therapeutics Stock 10-Day Winning Spree: Stock Climbs 35% - Trefis
TG Therapeutics Stock Surges 35%, With A 10-Day Winning Spree - Trefis
Jefferies Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $83 - Moomoo
TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotech Powerhouse with Robust Revenue Growth - DirectorsTalk Interviews
TG Therapeutics Stock Rockets 33% With 9-Day Winning Streak - Trefis
TG Therapeutics Stock 9-Day Winning Spree: Stock Climbs 33% - Trefis
TG Therapeutics rises on early-stage trial data for Briumvi injectable - MSN
Is TG Therapeutics, Inc. (TGTX) A Good Stock To Buy Now? - Insider Monkey
TG Therapeutics stock hits 52-week high at 54.04 USD By Investing.com - Investing.com Australia
TG Therapeutics Stock Surges 28%, With A 8-Day Winning Spree - Trefis
The Utter Rampage That Sent This Biotech Flying 79% - Investor's Business Daily
TG Therapeutics Stock Rises Thursday: What's Driving The Gains?TG Therapeutics (NASDAQ:TGTX) - Benzinga
TG Therapeutics Inc (TGTX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
TG Therapeutics stock hits 52-week high at 54.04 USD - Investing.com
Tg Therapeutics Inc (TGTX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):